Skip to content

A Study to Compare an Ayurvedic Herbal Paste and Thrombophob Ointment for Painful Swollen Veins

Randomized Double Arm Clinical Study to Evaluate the Efficacy of Shothagna Lepa Over Thrombophob Ointment in the Management of Siragata Vyadhi W.S.R To Superficial Thrombophlebitis - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/101207
Enrollment
40
Registered
2026-01-15
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I808- Phlebitis and thrombophlebitis ofother sites

Interventions

None listed

Sponsors

Dr Rudragowda S
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Established cases of Superficial Thrombophlebitis due to improper canulation in upper and lower limb will be included. Patients of irrespective of gender, between the age group of 18-70 years will be included.

Exclusion criteria

Exclusion criteria: Patients with Superficial thrombophlebitis due to other trauma except canula insertion, varicose veins, Deep Vein Thrombosis will be excluded. Patients with systemic diseases like AIDS, Tuberculosis, carcinoma, Venereal Disease, and any other Blood-borne Diseases will be excluded. Patients with uncontrolled hyperglycaemia HbA1c more than 8 percentage will be excluded. Patients with abnormal Bleeding time, Clotting Time and prothrombin will be excluded.

Design outcomes

Primary

MeasureTime frame
To evaluate the comparative efficacy and safety of Shothagna Lepa and Thrombophob Ointment in reducing pain, swelling, inflammation, and venous induration in patients with Siragata Vyadhi (Superficial Thrombophlebitis).Timepoint: 2 weeks

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDr Prabhakar H Taseen

Ayurveda Mahavidyalaya And Hospital

tasinph@gmail.com9844765647

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026